Boothbay Fund Management’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,146
| Closed | -$230K | – | 2077 |
|
|
2021
Q3 | $230K | Buy |
1,146
+213
| +23% | +$42.7K | 0.01% | 1260 |
|
|
2021
Q2 | $239K | Buy |
933
+363
| +64% | +$93K | 0.01% | 1250 |
|
|
2021
Q1 | $151K | Buy |
+570
| New | +$151K | 0.01% | 1183 |
|
|
2020
Q4 | – | Sell |
-1,262
| Closed | -$308K | – | 1327 |
|
|
2020
Q3 | $308K | Buy |
1,262
+855
| +210% | +$209K | 0.02% | 685 |
|
|
2020
Q2 | $117K | Sell |
407
-6
| -1% | -$1.73K | 0.01% | 738 |
|
|
2020
Q1 | $84K | Buy |
+413
| New | +$84K | 0.01% | 651 |
|
|
2019
Q1 | – | Sell |
-1,529
| Closed | -$466K | – | 829 |
|
|
2018
Q4 | $466K | Buy |
+1,529
| New | +$466K | 0.07% | 215 |
|
|
2018
Q3 | – | Sell |
-665
| Closed | -$243K | – | 864 |
|
|
2018
Q2 | $243K | Buy |
+665
| New | +$243K | 0.02% | 430 |
|